IRIS Accounts Production v25.2.0.378 13454688 director 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary 1.00000 Ordinary A shares 1.00000 Ordinary B shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh134546882024-03-31134546882025-03-31134546882024-04-012025-03-31134546882023-03-31134546882023-04-012024-03-31134546882024-03-3113454688ns15:EnglandWales2024-04-012025-03-3113454688ns14:PoundSterling2024-04-012025-03-3113454688ns10:Director12024-04-012025-03-3113454688ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3113454688ns10:SmallEntities2024-04-012025-03-3113454688ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3113454688ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3113454688ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3113454688ns10:FullAccounts2024-04-012025-03-3113454688ns10:OrdinaryShareClass12024-04-012025-03-3113454688ns10:OrdinaryShareClass22024-04-012025-03-3113454688ns10:OrdinaryShareClass32024-04-012025-03-3113454688ns10:RegisteredOffice2024-04-012025-03-3113454688ns5:CurrentFinancialInstruments2025-03-3113454688ns5:CurrentFinancialInstruments2024-03-3113454688ns5:ShareCapital2025-03-3113454688ns5:ShareCapital2024-03-3113454688ns5:RetainedEarningsAccumulatedLosses2025-03-3113454688ns5:RetainedEarningsAccumulatedLosses2024-03-3113454688ns5:FurnitureFittings2024-04-012025-03-3113454688ns5:ComputerEquipment2024-04-012025-03-3113454688ns5:PlantMachinery2024-03-3113454688ns5:PlantMachinery2024-04-012025-03-3113454688ns5:PlantMachinery2025-03-3113454688ns5:PlantMachinery2024-03-3113454688ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3113454688ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3113454688ns10:OrdinaryShareClass12025-03-3113454688ns10:OrdinaryShareClass22025-03-3113454688ns10:OrdinaryShareClass32025-03-31
REGISTERED NUMBER: 13454688 (England and Wales)














FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

DERMAP LTD

DERMAP LTD (REGISTERED NUMBER: 13454688)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


DERMAP LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: Dr A H Bhat





REGISTERED OFFICE: Ground Floor
Finchale House
Belmont Business Park
Durham
DH1 1TW





REGISTERED NUMBER: 13454688 (England and Wales)





ACCOUNTANTS: RMT Ribchesters
Accountants and Business Advisors
Finchale House
Belmont Business Park
Durham
DH1 1TW

DERMAP LTD (REGISTERED NUMBER: 13454688)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,911 3,819

CURRENT ASSETS
Debtors 5 10,229 105,322
Cash at bank 45,056 45,711
55,285 151,033
CREDITORS
Amounts falling due within one year 6 56,124 30,290
NET CURRENT (LIABILITIES)/ASSETS (839 ) 120,743
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,072

124,562

PROVISIONS FOR LIABILITIES 978 955
NET ASSETS 2,094 123,607

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 1,994 123,507
SHAREHOLDERS' FUNDS 2,094 123,607

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 13 October 2025 and were signed by:



Dr A H Bhat - Director


DERMAP LTD (REGISTERED NUMBER: 13454688)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Dermap Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Computer equipment - straight line over 3 years

Financial instruments
The company has elected to apply the provisions of section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

DERMAP LTD (REGISTERED NUMBER: 13454688)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Going concern
The director has considered the financial performance and position of the company and its cash flows for a period in excess of 12 months from the date on which their, financial statement were approved. He considers that the company can operate within the finances available to it. For this reason the going concern basis of accounting has been adopted.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2024 5,465
Additions 1,099
At 31 March 2025 6,564
DEPRECIATION
At 1 April 2024 1,646
Charge for year 1,007
At 31 March 2025 2,653
NET BOOK VALUE
At 31 March 2025 3,911
At 31 March 2024 3,819

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 10,229 105,322

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Amounts owed to group undertakings 35,000 -
Taxation and social security 17,559 24,147
Other creditors 3,565 6,143
56,124 30,290

DERMAP LTD (REGISTERED NUMBER: 13454688)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary £1.00 - 100
75 Ordinary A shares £1.00 75 -
25 Ordinary B shares £1.00 25 -
100 100

8. RELATED PARTY DISCLOSURES

During the year the company maintained an interest free loan to its parent company. At the year end the balance on the loan was £nil. (2024: £100,000).

During the year the company received an interest free loan from a group company. At the year end the balance on the loan was £35,000 (2024: NIL).

During the year the director maintained an interest free loan to the company. As at 31 March 2025 the balance on the loan was £NIL (2024: £3,743).